1. Endogenous chondroitin extends lifespan by inhibiting VHA-7-mediated tubular lysosome formation.
- Author
-
Shibata Y, Tanaka Y, Mori S, Mitsuzumi K, Fujii S, Sasakura H, Morioka Y, Sugioka K, Takeuchi K, and Nishiwaki K
- Subjects
- Animals, Mutation, Basement Membrane metabolism, Basement Membrane drug effects, Lysosomes metabolism, Lysosomes drug effects, Caenorhabditis elegans metabolism, Caenorhabditis elegans drug effects, Chondroitin metabolism, Caenorhabditis elegans Proteins metabolism, Caenorhabditis elegans Proteins genetics, Longevity drug effects
- Abstract
Chondroitin extends lifespan and healthspan in C. elegans, but the relationship between extracellular chondroitin and intracellular anti-aging mechanisms is unknown. The basement membrane (BM) that contains chondroitin proteoglycans is anchored to cells via hemidesmosomes (HDs), and it accumulates damage with aging. In this study, we found that chondroitin regulates aging through the formation of HDs and inhibition of tubular lysosomes (TLs). Reduction of chondroitin due to a mutation in sqv-5/Chondroitin synthase (ChSy) causes the earlier and excessive formation of TLs and leakage of the lysosomal nuclease in a manner dependent on VHA-7, the a-subunit of V-type ATPase. VHA-7, whose mutation suppresses the short lifespan of the sqv-5 mutant, is initially localized to the basal side of the hypodermal cells and transported to lysosomes with aging. These results demonstrate that endogenous chondroitin suppresses aging by inhibiting the earlier excessive formation of TLs. This is a novel anti-aging mechanism that is controlled by the BM., Competing Interests: Declarations. Competing interests: The authors declare no competing interests., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF